SciTransfer
Organization

NANOTYPOS EE

Greek SME providing nano-imprint lithography and nano-fabrication for optics, laser manufacturing, and biomedical nanostructures.

Technology SMEdigitalELSME
H2020 projects
4
As coordinator
0
Total EC funding
€1.0M
Unique partners
58
What they do

Their core work

Nanotypos is a Greek SME specializing in nano-fabrication and nano-imprint lithography, providing precision nanoscale patterning capabilities for industrial and biomedical applications. They bring nano-optics and laser-based manufacturing expertise to EU consortia, enabling partners to produce micro- and nano-structured surfaces for optics, automotive components, and biomedical implants. Their work spans from on-demand laser-printed prescription lenses to nanoparticle-based materials for in-vivo imaging and bioengineered implants.

Core expertise

What they specialise in

Nano-imprint lithography and nano-fabricationprimary
3 projects

Core capability across PULSE (nano-imprint lithography), ODYSSEY (nano-fabrication for lenses), and BIOMAC (nanomaterials processing).

Laser-based precision manufacturingprimary
2 projects

PULSE focused on ultrafast laser systems and polygon scanning; ODYSSEY applied laser printing for on-demand eyeglass production.

Nano-optics and optical componentssecondary
2 projects

ODYSSEY centered on nano-optics for prescription lenses; PULSE addressed automotive optical applications.

Bio-nanomaterials and biomedical nanostructuresemerging
2 projects

BIOMAC involves biopolymer nanomaterials; IN2SIGHT applies nanoparticles and biocompatibility testing for implant materials.

Multiphoton polymerization and advanced imagingemerging
1 project

IN2SIGHT uses 2-photon activated polymerization for in-vivo optical imaging windows.

Evolution & trajectory

How they've shifted over time

Early focus
Industrial nano-optics and laser manufacturing
Recent focus
Bio-nanomaterials and biomedical applications

Nanotypos entered H2020 with a clear industrial photonics focus — ultrafast lasers, polygon scanning, nano-imprint lithography for automotive and optical manufacturing (PULSE, ODYSSEY in 2019-2020). From 2021 onward, their work shifted significantly toward bio-nanomaterials and biomedical applications, joining projects on biopolymer nanomaterials (BIOMAC) and bioengineered implant imaging (IN2SIGHT). This pivot suggests they are applying their core nano-fabrication skills to the life sciences sector, a diversification that broadens their addressable market considerably.

Nanotypos is migrating its nano-fabrication expertise from pure industrial photonics toward biomedical and sustainable materials applications, positioning itself at the intersection of nanotechnology and life sciences.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European15 countries collaborated

Nanotypos operates exclusively as a participant, never coordinating — typical of a specialist SME that contributes deep technical capabilities rather than managing large consortia. With 58 unique partners across 15 countries from just 4 projects, they work in large, diverse consortia (averaging ~15 partners per project). This pattern indicates they are sought after as a niche technology provider whose nano-fabrication skills complement broader research efforts.

Despite only 4 projects, Nanotypos has built a wide network of 58 partners across 15 countries, indicating participation in large multi-national consortia. Their reach spans well beyond Greece, with strong European coverage typical of FET and RIA collaborative projects.

Why partner with them

What sets them apart

Nanotypos occupies a rare niche as a Greek SME with hands-on nano-imprint lithography and nano-fabrication production capabilities — not just research, but applied manufacturing at the nanoscale. Their ability to bridge industrial photonics (lasers, optics, automotive) and biomedical nanotechnology (implant materials, in-vivo imaging) makes them unusually versatile for an SME of their size. For consortium builders, they offer a practical nano-fabrication partner who can translate lab-scale nanostructures into functional prototypes.

Notable projects

Highlights from their portfolio

  • ODYSSEY
    Largest single grant (EUR 424,688) and a compelling real-world application: laser-printing prescription eyeglasses on demand in retail shops.
  • IN2SIGHT
    Represents their boldest pivot — applying nano-fabrication to bioengineered in-vivo imaging chips for preclinical validation, far from their industrial roots.
  • BIOMAC
    Their largest long-running project (EUR 339,938), connecting them to the European sustainable bio-nanomaterials community with standardization and open collaboration goals.
Cross-sector capabilities
healthmanufacturingenvironment
Analysis note: Profile based on 4 projects (2019-2021 start dates), all as participant. No website available for independent verification of commercial activities. The nano-fabrication specialization is well-supported by keyword evidence across projects, but the biomedical pivot is inferred from only 2 recent projects and may reflect opportunistic consortium joining rather than a strategic shift. Company is based in Volvi (rural northern Greece), which is unusual for a nanotechnology firm — worth verifying operational location.